France· FR:69966525
IMCIVREE 10 mg/ml, solution injectable
A setmelanotide product containing setmélanotide, registered in France by RHYTHM PHARMACEUTICALS NETHERLANDS (PAYS-BAS), on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Setmelanotide is registered in 12 of 19 countries.
Countries holding a registration under ATC A08AA12 (setmelanotide), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Setmelanotide · ATC A08AA12
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- SETMÉLANOTIDE
- Manufacturer
- RHYTHM PHARMACEUTICALS NETHERLANDS (PAYS-BAS)
- Country
- France (FR)
- ATC code
- A08AA12
- ATC class
- Setmelanotide
- Defined daily dose
- 1.5 mg, P
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400930236567flacon(s) multidose(s) en verre de 1 mlEUR 1.79
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Setmelanotide in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandIMCIVREE 10 mg/ml solution for injectionRhythm Pharmaceuticals Netherlands B.V
- NetherlandsImcivree 10 mg/ml oplossing voor injectieRhythm Pharmaceuticals Netherlands B.V.
- CzechiaIMCIVREERhythm Pharmaceuticals Netherlands B.V., Amsterdam
- IcelandIMCIVREERhythm Pharmaceuticals Netherlands B.V
- SwitzerlandIMCIVREE 10 mg/ml, InjektionslösungRhythm Pharmaceuticals Switzerland GmbH
- SpainIMCIVREE 10 MG/ML SOLUCION INYECTABLERhythm Pharmaceuticals Netherlands B.V.
- FinlandImcivreeRhythm Pharmaceuticals Netherlands B.V.
- United KingdomImcivree 10mg/1ml solution for injection vialsRhythm Pharmaceuticals UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Imcivree
- Liechtenstein · Imcivree
- Norway · Imcivree
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/8b7a5298-2eb8-4a09-8080-d5266a81d82f GET /v1/drugs/8b7a5298-2eb8-4a09-8080-d5266a81d82f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69966525",
"date_amm": "2021-07-16",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/21/1564",
"substance": "SETMÉLANOTIDE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "sous-cutanée",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about setmelanotide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.